Featuring patient case presentations by Dr
Jacqueline T Brown and Dr Nazli Dizman, with commentary from Dr
Matthew Milowsky, including the following topics:
Case: A man in his mid 50s with metastatic recurrence of
urothelial bladder cancer (UBC) after neoadjuvant
cisplatin/gemcitabine receives first-line enfortumab vedotin
(EV)/pembrolizumab (0:00)
Case: A man in his early 50s with muscle-invasive bladder
cancer (MIBC) receives adjuvant pembrolizumab, experiences disease
progression and then receives EV monotherapy (12:33)
Case: A man in his late 80s with recurrent metastatic UBC after
pembrolizumab therapy for MIBC receives EV monotherapy at a reduced
dose (24:07)
Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.